Imperial College London
Portrait Picture

Dr Mark P. Lythgoe

Faculty of Medicine, Department of Surgery & Cancer

Research Postgraduate
 
 
 
//

Contact

 

m.lythgoe

 
 
//

Location

 

Institute of Reproductive and Developmental BiologyHammersmith Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Lythgoe:2020:10.1016/j.tips.2020.03.006,
author = {Lythgoe, MP and Middleton, P},
doi = {10.1016/j.tips.2020.03.006},
journal = {Trends in Pharmacological Sciences},
pages = {363--382},
title = {Ongoing clinical trials for the management of the COVID-19 pandemic},
url = {http://dx.doi.org/10.1016/j.tips.2020.03.006},
volume = {41},
year = {2020}
}
Download

RIS format (EndNote, RefMan)

TY  - JOUR
AB  - COVID-19 has rapidly developed into a worldwide pandemic with a significant health and economic burden. There are currently no approved treatments or preventative therapeutic strategies. Hundreds of clinical studies have been registered with the intention of discovering effective treatments. Here, we review currently registered interventional clinical trials for the treatment and prevention of COVID-19 to provide an overall summary and insight into the global response.
AU  - Lythgoe,MP
AU  - Middleton,P
DO  - 10.1016/j.tips.2020.03.006
EP  - 382
PY  - 2020///
SN  - 0165-6147
SP  - 363
TI  - Ongoing clinical trials for the management of the COVID-19 pandemic
T2  - Trends in Pharmacological Sciences
UR  - http://dx.doi.org/10.1016/j.tips.2020.03.006
UR  - https://www.sciencedirect.com/science/article/pii/S0165614720300705?via%3Dihub
UR  - http://hdl.handle.net/10044/1/79150
VL  - 41
ER  -
Download